<code id='9350F735DC'></code><style id='9350F735DC'></style>
    • <acronym id='9350F735DC'></acronym>
      <center id='9350F735DC'><center id='9350F735DC'><tfoot id='9350F735DC'></tfoot></center><abbr id='9350F735DC'><dir id='9350F735DC'><tfoot id='9350F735DC'></tfoot><noframes id='9350F735DC'>

    • <optgroup id='9350F735DC'><strike id='9350F735DC'><sup id='9350F735DC'></sup></strike><code id='9350F735DC'></code></optgroup>
        1. <b id='9350F735DC'><label id='9350F735DC'><select id='9350F735DC'><dt id='9350F735DC'><span id='9350F735DC'></span></dt></select></label></b><u id='9350F735DC'></u>
          <i id='9350F735DC'><strike id='9350F735DC'><tt id='9350F735DC'><pre id='9350F735DC'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:66
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Correcting Robert F. Kennedy Jr.'s vaccine 'facts'
          Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

          JustinSullivan/GettyImagesWhenpeoplemisrepresentfactsontherecord,journalistsareinatoughspot—especial

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Fatty liver disease was alleviated by Lilly’s ‘triple

          Largevacuolesoftriglyceridefat,accumulatedinsidelivercells.AdobeSANDIEGO—Anexperimentalobesitydrugfr